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Atrial natriuretic peptide and the renal response to hypervolemia in
nephrotic humans. To elucidate the abnormality of body fluid homeo-
stasis that attends the nephrotic syndrome, we compared the atrial
hormonal and renal excretory and vasomotor responses to water
immersion of nephrotic patients (N = 10) with those of healthy controls(N = 9). Nephrotics exhibited depressed baseline levels of atrial
natriuretic peptide (ANP, P < 0.05) and lower rates of urine flow and
sodium excretion (P < 0.01). Although immersion-induced hypervol
emia increased plasma ANP to equivalent levels (75 19 vs. 60 6pg/
ml), the disparity in corresponding urinary flow (5 1 vs. 13 2 ml!
mm, P < 0.01) and sodium excretion (171 42 vs. 540 65 sEq/min,P < 0.01) grew larger. In contrast, immersion caused an equivalent
reduction of renal vascular resistance by 16 and 17%, respectively (P <
0.01). Despite higher renal plasma flow and lower oncotic pressure of
plasma, the glomerular filtration rate remained constant during immer-
sion in both groups. Similar constancy of fractional clearances of
dextrans of graded size suggests that immersion may have lowered the
glomerular transcapillary hydraulic pressure difference (i.P). We con-
clude that renal vasomotor responsiveness to hypervolemia is pre-
served in nephrotics, but that the mediatory role of ANP in this
response is uncertain. By contrast, diminished responsiveness of the
distal nephron to the natriuretic action of endogenous ANP could
contribute to edema formation in the nephrotic syndrome.
The mechanism by which nephrotic subjects form edema
remains an enigma. It has been proposed that renal sodium and
water retention is a consequence of the hypoalbuminemia that
attends massive urinary losses of protein. According to this
theory, lowered plasma oncotic pressure permits extracellular
fluid to be translocated from the vascular to the interstitial
compartment. An ensuing reduction of "effective" plasma
volume is then postulated to result in a series of neurohormonal
adaptations which stimulate renal sodium retention [1—31.
Among these adaptations may be depression of the ambient
levels of the atrial natriuretic peptide (ANP). A second expla-
nation is that intrinsic injury to the nephron leads to a primary
enhancement of tubular sodium reabsorption that is indepen-
dent of events in the systemic circulation [4, 5]. In keeping with
this possibility, infusion of exogenous ANP into nephrotic rats
has been associated with a blunted diuretic and natriuretic
response to the peptide [6, 7]. Preservation of vasomotor
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responsiveness suggested a specific defect of ANP action on the
tubule [6].
To elucidate the possible contribution of ANP to body fluid
homeostasis, we subjected nephrotic subjects and healthy vol-
unteers to water immersion, a maneuver that leads to atrial
distention [8], enhanced release of ANP [9] and an ensuing
diuresis and natriuresis [8—12]. We used a differential solute
clearance technique to compare the renal vasomotor and excre-
tory responses to the transient hypervolemia in the two groups.
Our findings suggest that renal cortical vessels of nephrotic
subjects are normally responsive, but that their tubules exhibit
insensitivity to immersion-induced natriuretic influences, in-
cluding enhanced release of endogenous ANP. An inability to
mount a normal diuretic and natriuretic response to transient
hypervolemia may contribute to the enlargement of interstitial
fluid volume that typifies the nephrotic syndrome.
Methods
Study populations
Ten patients referred consecutively to us because of the
development of a nephrotic syndrome and aged 16 to 54 years
comprised the experimental population. In each instance daily
urinary protein losses in excess of 4 g were accompanied by
hypoalbuminemia and edema. Renal biopsy revealed a variety
of underlying glomerular diseases, including lupus-associated
proliferative glomerulonephritis (N = 2), membranous glomer-
ulopathy (N = 3), and minimal change glomerulopathy with or
without focal and segmental glomerulosclerosis (N = 5). Nine
healthy volunteers who ranged in age from 19 to 51 years served
as a control group. All denied a history of renal disease,
diabetes or hypertension, and were found at the time of
examination to be normotensive and to have a negative dipstick
test for urinary protein.
Study protocol
The study protocol, approved previously by the institutional
review board at Stanford University Medical Center, was
described in detail and informed consent to perform the study
was obtained from each patient and volunteer. Ambient levels
of plasma ANP were determined in a clinical research center.
Each subject remained seated in a chair for at least one hour
before blood was sampled. Blood was placed immediately in a
chilled heparinized tube containing 1 mg/mI of disodium ethyl-
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enediamine tetraacetrate (EDTA) and 500 KIU/mI of Aprotinin
(Sigma Chemicals Co., St. Louis, Missouri, USA). Plasma was
separated by centrifugation at 2500 rpm for 15 minutes and
stored at —70°C until the day of assay. These determinations
were made at 0.900 hours following a light breakfast, and in the
case of the proteinuric patients, after discontinuation of antihy-
pertensive and diuretic drugs for the four days preceding the
study.
Each patient and volunteer was then subjected to differential
solute clearances and head-out water immersion. A priming
infusion containing 10% inulin (60 mg/kg), 20% para-aminohip-
puric acid (PAH, 8 mg/kg), and 10% dextran 40(130 mg/kg) was
administered. Thereafter, inulin and PAH were infused contin-
uously at a rate calculated to maintain their respective plasma
concentrations constant at 20 and 1.5 mg/dl. During a 60-minute
equilibration period, a solution of 0.45% saline in 2.5% dextrose
was infused at 10 ml per kg body weight to promote a diuresis.
Four accurately-timed urine collections were then obtained by
spontaneous voiding. Peripheral venous blood was drawn from
an indwelling cannula to bracket each urine collection. The
average inulin clearance for the four collection periods was
equated with the glomerular filtration rate (GFR). Renal plasma
flow (RPF) was calculated by dividing the corresponding PAH
clearance by an estimate of the renal extraction ratio of PAH
(EpAH). In the healthy volunteers, we used a ratio of 0.85 [13,
14]. However, EPAH has been shown to be moderately de-
pressed in patients with proteinuric glomerular diseases [15—
18], To define a representative value of EPAH for the experi-
mental group, we determined this quantity directly in seven
nephrotic subjects, two of whom were members of the experi-
mental population. All were undergoing catheterization to ex-
clude a renal vein thrombosis and had been shown by biopsy to
have either membranous (N = 4), lupus related (N = 1), or focal
sclerosing glomerulopathy (N = 2). Renal and peripheral ve-
nous blood was sampled simultaneously during an infusion of
PAH, identical to that used during the clearance studies. EPAH
was depressed uniformly, varying between 0.58 and 0.80 and
averaging 0.68 0.04. Based on the latter value we assumed
that EPAH during our clearance studies approximated 0.7 in
each member of the experimental group. Renal blood flow was
calculated by dividing RPF by (1-hematocrit), and renal vascu-
lar resistance was derived by dividing arterial pressure by renal
blood flow.
Fractional dextran clearances (OD) were computed using the
equation:
Or, = (U/P),I(U/P)11, (1)
where (U/P)r, and (UIP)1 refer to the urine-to-midpoint plasma
concentration ratio of dextran and of inulin, respectively.
Because dextran is neither reabsorbed nor secreted by the
tubule, its fractional clearance equals its Bowman's Space-to-
plasma concentration ratio, or sieving coefficient [19, 201.
Upon completion of the baseline clearances, central volume
expansion was induced by immersing the subject up to the
neck, while seated in a tank of water, the temperature of which
was maintained constant between 34.5° and 35.5°C. A second
period of one hour was then allowed to elapse to permit the
subject to re-equilibrate and adapt to the acute, central volume
expansion. Another set of four clearance measurements was
then made at 30 minute intervals. These coincided with the
second and third hours of water immersion, a period which has
been shown to be associated with peak volume expansion and a
corresponding maximal renal response to the hypervolemia [8—
12]. Urinary losses were replaced quantitatively throughout by
intravenous infusion of 0.45% saline in 2.5% dextrose solution.
The following were determined in duplicate before the priming
infusion, during the baseline clearances, at hourly intervals
during the three hour period of water immersion, and again one
hour after immersion; heart rate, arterial blood pressure (cal-
culated as diastolic pressure plus one-third of pulse pressure),
hematocrit (Hct), plasma protein concentration and oncotic
pressure, and plasma levels of ANP.
Laboratory procedures
Plasma and urinary concentrations of inulin and PAH were
analyzed using techniques that have been described previously
[21]. Separation of dextran 40 in protein-free filtrates of plasma
and urine into narrow fractions was achieved by high perfor-
mance liquid chromatography using a pump (#2010, Varian,
Palo Alto, California, USA) and two Micropak TSK columns in
series (SW 3000 and SW 4000, Toyosoda, Tokyo, Japan). The
columns were calibrated with three, narrowly dispersed dex-
trans and an inulin preparation, all of known molecular weight
(70, 40, 10 and 5.5 kilodaltons, respectively). Blue dextran was
used to identify the void volume. Dextran concentration was
measured using an "on-line" refractive index detector (#RS-3,
Varian). An integrator (#4270, Spectraphysics, San Jose, Cal-
ifornia, USA) was used to devide the chromatogram into four
slices per minute at a chart speed of 0.25 cm/mm during the 30
minute run. The integrated area of each slice was equated with
the dextran concentration at the corresponding retention time.
Molecular radius (r) was computed from the linear relationship
between retention time and molecular weight (MW), where:
r 0.33 x (MW)°463 (2)
The fractional clearances (0) of each discrete dextran fraction at
2 A intervals over the molecular radius range, 30 to 54 A, were
computed using equation (1).
Total solute concentration in urine and plasma was measured
by freezing point depression, while corresponding sodium con-
centrations were determined by flame photometry. Albumin
and JgG concentrations in unconcentrated urine were deter-
mined by a sensitive enzyme-linked immunosorbent assay using
alkaline phosphatase-linked goat antibodies to human albumin
and IgG (Tago Inc., Burlingame, California, USA). Oncotic
pressure of plasma was determined directly using a membrane
osmometer (IL Weil Oncometer-TM, Lexington, Massachu-
setts, USA).
Radioimmunoassays
Plasma samples were thawed on the day of assay. ANP was
extracted from acidified plasma by Sep-pak C 18 column
chromatography (Waters, Milford, Massachusetts, USA). The
columns were pretreated with methanol, washed first with
distilled water and then with 4% acetic acid. ANP was eluted
with 75% acetone in 25% 0.2 N HCL, and the samples allowed
to dry in a Savant Speed Vac centrifuge. The samples were
dissolved in a standard RIA buffer containing 1 mrs EDTA.
Synthetic a-human ANP [1-281 (Peninsula Laboratories, Bel-
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Table 1. Systemic effects of immersion
Hematocrit
Serum
protein gidi
Normal controls
Time 0
Baseline
Immersion hr 1
hr2
hr 3
Post-immersion
Nephrotics
Time 0
Baseline
Immersion hr 1
hr 2
hr 3
Post-immersion
0.46 0.01
0.44 0.01
0.43 0.Ola
0.43 0.Ola
0.42 0.OIa
0.44 0.01
0.43 0.01
0.39 o.ola
0.39 0.OIa
0.39 0.Ola
0.38 0.ola
0.40 0,Ola
6.8 0.16
6.4 0.16
ND
6.2 o.lla
ND
6.4 0.lSa
4.9 0.23
4.6 0.22a
4.5 o.23
44 0.26a
4.4 0.22a
4.7 o.21a
Abbreviation ND is not done. a Differs from time 0 at P < 0.05
mont, California, USA) was used as the standard. Standard or
sample was preincubated with antibody (Peninsula Laborato-
ries) for 24 hours at 4°C; ['251]a-human ANP (Peninsula Labo-
ratories) was added and incubation continued for 24 hours at
4°C. Bound ligand was separated and counted using standard
techniques. A standard curve was calculated for each experi-
ment using a four parameter program (Micromedic Systems,
Horsham, Pennsylvania, USA). The half-maximal binding
(ED50) for the assay was 13 to 16 pg/tube, while the minimal
detectable level of ANP was 3 pg/tube. The intra- and inter-
assay coefficients of variation were 4 and 14%, respectively (N
= 10). Recovery of ANP from the column averaged 79%.
Statistical methods
Intragroup differences between baseline and immersion were
analyzed by an analysis of variance (ANOVA) with repeated
measures using the CLINFO system. Actual differences in
values at baseline and during immersion among the two groups
were assessed using an unpaired Student's (-test. All results are
expressed as the mean SEM.
Results
The systemic effects of immersion are summarized in Table 1
and Figure 1. Judged by a reduction of Hct and total protein
concentration in plasma, the priming infusion led to modest
hemodilution. Both Hct and total protein concentration fell
further during water immersion, reaching nadir levels during the
second and third hours. Hct fell by 9% from an initial value of
46 1 to a nadir of 42 1% in controls, and by 12% from 43
1 to 38% 1 in nephrotic subjects (P < 0.01). Corresponding
reductions of total protein concentration were by 9 and 10%,
respectively (P < 0.01). Initial ANP levels were lower in the
nephrotic (14 3) than in normal controls (34 3 pg/mI, P <
0.05). However, the peak levels achieved by each group during
the third hour of immersion tended to be higher in nephrotics
(75 19) than in controls (60 6 pg/ml, P = NS, Fig. 1). The
333% increase in nephrotic subjects was significantly larger
than the corresponding 63% increment observed in controls (P
<0.05).
The excretory response to immersion is summarized in Table
2. The baseline rates of urine flow and the clearance of solute
Solute-free
water
Urine flow clearance NA*excretion
g/min
Fractional
Na
excretion
(%)mi/mm
Normal controls
Baseline 7.8 1.6 +3.8 1.7 201 31 1.24 0.19
Immersion 12.9 1.6 +7.5 1.5C 540 85° 3.39 0.53c
% Change + 65 + 169 + 173
Nephrotics
Baseline 3.1 0.7 —0.1 0.4a 114 25 1.78 0.72
Immersion 4.6 11b +1.6 07b 171 42b,c 2.19 0.58c
% Change + 47 + 50 + 23
free water were lower in nephrotics than controls, with the
latter difference reaching statistical significance. Controls dem-
onstrated a significant twofold increase in each quantity when
immersed. However, immersion of nephrotics induced smaller
corresponding increments that failed to achieve statistical sig-
nificance, with the result that the initial disparity between the
two groups grew even larger. A similar trend was observed for
urinary sodium excretion rate. A lower baseline value and
smaller, albeit significant increase during immersion resulted in
the latter excretion rate being 3.2 times lower than that in
controls. In contrast to absolute excretion, the baseline frac-
tional excretion of sodium was similar in the two groups, and
increased significantly during immersion of each. The relative
increment in fractional sodium excretion was larger in controls
than nephrotics however, 173 versus 23% (P < 0.05). Thus
a-z
a
E
a0
Hours of immersion
Fig. 1. Mean plasma ANP levels before infusion (time 0), during
baseline clearances (base) and in the middle of each hour of water
immersion, Controls are depicted by open symbols. Nephrotics are
depicted by closed symbols. tP < 0.05 vs. controls; * < 0.05 vs. time
0.
Table 2 Excretory response to immersion
TimeO Base 1 2 3
a Differs from control baseline value at P < 0.05
b Differs from control immersion value at P < 0.05
Paired, intragroup difference from baseline at P < 0.05
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Table 3. Vasomotor response to immersion
Renal
vascular
Mean arterial Renal blood resistance
pressure Heart rate flow mm
mm Hg beats/mm mi/mm Hg. mm/liter
Normals
Baseline 89 3 67 5 1165 69 72 2
Immersion 81 3C 70 7° 1288 110° 60 3°
%Change —10 +4 +11 —17
Nephrotics
Baseline 103 7 69 2 973 140 112 16
Immersion 90 8b,c 80 1076 167 95 15°
%Change —13 +16 +11 —16
a, b and C are as for Table 2.
0 50 100 150 200 250 300
Baseline, mm Hg•min//iter
Fig. 2. Renal vascular resistance during immersion versus baseline
value. The solid line is the line of identity. The slope of the regression
line (dashed) has been derived by linear regression analysis. Symbols
are: (0) controls; (•) nephrotics.
despite similarly high ambient levels of ANP during immersion,
the diuretic and natnuretie responses of nephrotics were blunt-
ed when compared to controls.
The renal vasomotor response to immersion is summarized in
Table 3. Immersion was accompanied in each group by a
significant fall in arterial pressure, from 89 3 to 81 3 mm Hg
in controls, and from 103 7 to 90 8 mm Hg in nephrotics.
There was a reciprocal increase in heart rate in each group.
Baseline renal blood flow was similar in the two groups; 1165
69 in controls and 973 140 ml/min per 1.73 m2 in nephrotics (P
= NS). Renal blood flow increased by 11% during immersion of
both groups, although only the increment in controls reached
significance. Whereas calculated renal vascular resistance was
narrowly distributed in controls, it varied widely among ne-
phrotics. Regardless of the initial value however, immersion
lowered renal vascular resistance uniformly and by a similar
amount in the members of each group (Fig. 2); on average, this
was from 72 2 to 60 3 in controls (P < 0.01), and from 112
16 to 95 15 (mm Hg. mm) per liter in nephrotics (P <
0.005, Table 3).
Glomerular filtration dynamics are summarized in Table 4.
Despite a similar rate of RPF and substantially lowered 1Ta the
baseline GFR was lower by almost half in nephrotics than in
controls, 56 9 versus 109 + 4 mllmin per 1.73 m2, respectively
(P < 0.001). Respective rates of RPF increased by 12 and 14%
during immersion of the two groups. In keeping with the
hemodilution of plasma proteins observed during immersion,
mean plasma oncotic pressure fell by 1.2 mm Hg in nephrotics
(P < 0.005) and by 1.4 mm Hg in controls (P = 0.07). An
increase in the flow rate and a reduction of the oncotic pressure
of plasma entering the glomerular capillary network are pre-
dicted to increase ultrafiltration pressure. Yet GFR tended to
decline, albeit only slightly, in both groups during immersion.
Similarly there was a small but highly significant reduction of
the filtration fraction in each group. In contrast to the blunted
excretory response of nephrotics during immersion, their renal
vasomotor responsiveness to this maneuver was qualitatively
and quantitatively similar to that of normal controls.
Mean dextran sieving coefficients during immersion of both
controls and nephrotic subjects are compared to corresponding
baseline values in Figure 3. Because smaller constituent mole-
cules of the dextran 40 infusate had been largely excreted by the
time of immersion, the comparison to baseline is limited to
dextrans of radius between 36 and 54 A. In keeping with the
known sieving behavior of nephrotic glomeruli, the transglome-
rular transport of relatively permeant dextrans of below 52 A
radius was substantially depressed below control values [15, 21,
22]. Neither group had dextran sieving coefficients influenced
by immersion, however; they were essentially unchanged from
euvolemic values over the entire range of molecular radii that
remained measurable. The rate of urinary albumin and IgG
excretion in each group is summarized in Table 4. Consistent
with the constancy of the fractional dextran clearance profiles
before and during immersion, the level of proteinuria was not
influenced by immersion. Thus, the alteration of glomerular
pressures and flows associated with this perturbation does not
appear to have had any effect on barrier size-selectivity.
Discussion
The finding of low ambient plasma ANP levels in the ne-
phrotic subjects of the present study is consistent with the
theory that an underfilled plasma compartment might behave as
a stimulus for sodium retention and edema formation. Because
of a profound lowering of the prevailing oncotic pressure of
plasma in the nephrotic group, it is conceivable that extracel-
lular fluid was translocated from the plasma to the interstitial
space. A consequent contraction of effective plasma volume
would likely be sensed in the cardiac atrial chambers, and
explain the apparently diminished release of active ANP from
its storage sites into the circulation. Low levels of this natri-
uretic substance in the renal circulation might then contribute to
the observed tendency towards sodium retention. However,
sodium retention and edema have been observed in patients
with cardiac failure, in whom circulating levels of ANP are
elevated [23, 241. Moreover, the rates of diuresis and natriuresis
in the nephrotic subjects of the present study remained well
below control levels (Table 2), even after plasma volume had
been expanded and ANP elevated to equivalent levels (Fig. 1).
Presumably factors other than an underfilled plasma compart-
ment must contribute to the state of sodium retention.
250 —
200 —
C0
E
E
150 —
100
50
0
S
= 0.924
I I I
Peterson et al: Nephrotic response to hypervolemia 829
Table 4. Glomerular filtration dynamics
IgG
Glomerular
filtration rate
Renal plasma
flow Filtration
fraction
Oncotic
pressure
mm Hg
Albumin
excretion rate
excretion
rate
mi/mm g/min
Normals
Baseline 109 4 644 31 0.173 0.006 24.1 0.93 5.8 0.6 1.3 0.3
Immersion 106 4 735 57C 0.149 0.008c 22.7 0.62 6.8 1.2 1.2 0.3
%Change —3 +14 —14 —6 +15 —8
Nephrotics
Baseline 56 9 588 81 0.097 0.009 13.1 l.22a 7226 2137k 343 152
Immersion 55 8" 660 100 0.090 0,O1O1.c 11.9 7120 1798" 335 133b
%Change —2 +12 —7 —9 —1 —2
a, b and are as for Table 2.
Co
Co
a,
C
Co
x
a,
CoC0
C.,
Co
U-
Dextran radius, A
Fig. 3. Mean dextran sieving coefficients in healthy controls (circles)
are compared with those of nephrotic subjects (triangles). Baseline
values (closed symbols) are joined by an unbroken line, while values
during immersion (open symbols) are joined by a dashed line.
Another possible explanation is that direct injury to the
nephron rather than a systemic abnormality might be primarily
responsible for sodium retention in the nephrotic syndrome.
The most compelling evidence in support of this hypothesis is
provided by a rat model in which injection of aminonucleoside
into a single renal artery has been used to induce a unilateral
proteinuric injury [4, 5]. Although the uninjured contralateral
kidney was exposed to the same systemic and hormonal influ-
ences, only the aminonucleoside-injected kidney demonstrated
avid sodium retention.
Micropuncture studies of rats with both the unilateral [51 and
bilateral models of the nephrotic syndrome [25, 26] have
revealed absolute proximal reabsorption to be depressed. So-
dium delivery to the distal tubule was enhanced under condi-
tions of either hydropenia [26], euvolemia [5] or hypervolemia
[25], a phenomenon that was attributed to depression of oncotic
pressure in the proximal peritubular circulation. A tendency
towards overall renal sodium retention was localized to the
collecting duct [5, 25]. In light of the hemodilution and lowered
filtration fraction that were associated with water immersion,
the oncotic pressure of postglomerular plasma must have been
lowered also in immersed nephrotic subjects of the present
study. If, as in the nephrotic rat, a corresponding increase in
sodium delivery out of the proximal tubule eventuated, it
follows that enhanced distal tubular reabsorption of sodium and
water must account for the blunting of fractional sodium
excretion and impaired ability to elaborate solute-free water
that we observed during immersion of these subjects (Table 2).
A considerable body of evidence now points to the inner
medullary segment of the collecting duct as the site at which
ANP exerts its major action to inhibit sodium reabsorption [27—
31]. In accord with possible inactivity of ANP at this site in the
nephrotic rat, the sodium retention associated with adriamycin-
induced nephropathy has recently been shown to be unrespon-
sive to infusion to ANP [6, 7]. Although by no means an
exclusive explanation for sodium retention in our nephrotic
subjects, insensitivity of the collecting duct to an immersion-
induced elevation of endogenous plasma ANP is consistent with
their failure to mount a diuretic and natriuretic response of
normal magnitude. Our findings are also consistent, however,
with a generalized non-specific insensitivity of tubules in the
nephrotic kidney to a variety of natriuretic influences that
accompany immersion. These include depression of circulating
levels of arginine vasopressin [8] and various catecholamines
[12], and inhibition of the renin-angiotensin-aldosterone system
[9].
In contrast to their blunted excretory response to immersion,
the vasomotor response of the nephrotic group was nearly
identical to that of controls (Tables 3, 4, Fig. 2). Whereas the
cortical vasculature, and the glomeruli in particular, have been
shown to be endowed with a high density of ANP receptors [32,
33], the nature of the vasomotor response to immersion in each
group calls into question the importance of a specific mediatory
role for ANP. The predominant action on the renal cortical
circulation observed during infusion of ANP has been an
elevation of the GFR, with little or no corresponding increase in
RPF [34, 35]. The ensuing rise in filtration fraction has been
shown in the rat to result from an increase in glomerular
perfusion pressure, which in turn is brought about by an effect
to lower afferent arteriolar tone while elevating tone in the
efferent arterioles [35, 36].
Contrary to these reported effects of ANP on renal cortical
microvessels, and in keeping with the response in humans to
other forms of acute hypervolemia [14, 15, 37], immersed
controls of the present study exhibited an increase in renal
plasma flow and constancy of GFR (Table 3). The resultant
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lowering of filtration fraction is more consistent with a decline
rather than an elevation of glomerular perfusion pressure [38].
Also pointing away from any alteration in cortical segmental
resistance that might have elevated the glomerular perfusion
pressure during immersion is the absence of an increase in the
level of proteinuria [15, 39, 40]. That immersion may well have
lowered P is supported by the observed constancy of the
fractional dextran clearance profiles.
It has been shown that transcapillary dextran transport is
governed not only by the intrinsic properties of the glomerular
capillary wall, but also by the hemodynamic determinants of
GFR [41, 42]. Applying dextran sieving coefficients to a theo-
retical model of hindered solute transport through an isoporous
membrane, it has been estimated that the radius of hypothetical
pores that perforate the glomerular capillary wall of the rat is
not influenced by a large increase in plasma volume [20]. If this
is true also for volume expanded man, one would predict that
immersion induced changes in RPF and u'a would have lowered
the sieving coefficients of the infused dextrans. Afferent protein
concentration (CA) in immersed controls declined from 6.4 to
6.2 gldl (Table 1). From the quotient CA/(1-filtration fraction),
we estimate that the corresponding efferent protein concentra-
tion declined from 8.1 to 7.5 gIdl [361. Corresponding reductions
in nephrotic subjects were from 4.6 to 4.4 for afferent, and from
5.1 to 4.8 g/dl for efferent protein concentration, respectively. A
parallel reduction of intraluminal concentrations of restricted
dextran macromolecules along the glomerular capillaries is
predicted to have towered convective and diffusive transmem-
brane transport [22, 41, 42]. However, the observed failure of
dextran sieving coefficients to become depressed during immer-
sion can be reconciled if glomerular perfusion pressure, and
hence the transcapillary hydraulic pressure gradient (P), de-
clined in parallel with arterial pressure. A lowered iP is
predicted to increase transmembrane transport of uncharged
dextrans, a change which could have offset the opposite influ-
ence of elevated RPF and reduced ira[41, 42]. A decline in P
would also counter the effects of increasing RPF and declining
lTa to enhance ultrafiltration pressure, and explain the observed
constancy of GFR during immersion [38].
The seeming discrepancy between the effects on glomerular
filtration dynamics of infused synthetic ANP and those ob-
served during immersion induced release of endogenous ANP
in the present study could have several explanations. The
increase in efferent arteriolar tone and zP associated with ANP
infusion could well reflect a pharmacologic rather than a phys-
iologic action of the peptide. Infusion of ANP at doses that
elevate the filtration fraction in man have been associated with
plasma levels of ANP (625 to 2200 pg/ml) that are one to two
orders of magnitude higher than those observed by us during
immersion [23, 24, 43, 44]. Another possible explanation is that
ANP infusion differs from volume expansion in that atnal filling
pressures are lowered by the former, rather than elevated [23].
The lowered atrial pressure in turn could promote efferent
arteriolar constriction by increasing efferent sympathetic ner-
vous traffic to the kidney [45]. Indeed, prior renal denervation
in the nephrotic rat has been shown to partially correct renal
unresponsiveness to the actions of infused ANP [7]. Finally, it
is not unlikely that any action of ANP released during immer-
sion on renal cortical microvessels was a modulatory one only;
other neurohormonal adaptations to the associated hypervol-
emia may have predominated. As stated previously, such
adaptations include depression of circulating levels of various
vasoconstrictor hormones with a primarily efferent arteriolar
site of action, such as angiotensin II [9], arginine vasopressin
[8], and various catecholamines [12]. Retention of appropriate
reactivity to declining levels of these vasoconstrictor hormones
by the renal vasculature of our immersed nephrotic subjects
might explain their ability to lower renal vascular resistance and
the filtration fraction, while exhibiting an apparent, coincidental
insensitivity to the natriuretic action of ANP in the distal
nephron.
We propose that the development of the nephrotic syndrome
is associated with tubular insensitivity to ANP, and perhaps
also to other hormones that normally regulate tubular sodium
transport. An ensuing retention of sodium during transient
episodes of hypervolemia might then lead to a gradual increase
in extracellular fluid volume. The ultimate development of
edema could be dependent, however, on the presence of
additional factors. Two such factors that are likely to facilitate
the development of edema are discernable from a comparison of
findings in our nephrotic and control groups. The substantially
lower GFR in the former would likely increase the extent to
which sodium and water are added to the extracellular fluid with
the passage of time. Their profoundly lowered oncotic pressure
would favor translocation of the retained fluid from the plasma
to the interstitial compartment. We submit, therefore, that
while multiple factors might act in concert to produce edema in
proteinuric patients, an underlying insensitivity of the collecting
duct to the natriuretic actions of ANP may be both an initiating
event, and an important perpetuating factor in the development
of an edematous state.
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